Infectious Disease

Dose-sparing mpox vaccine regimen is safe and effective

May 3, 2024 - Research presented at the European Society of Clinical Microbiology and Infectious Diseases Global Congress in Barcelona on April 27, 2024, revealed that a dose-sparing mpox vaccine regimen offered the same antibody response as the standard protocol at six weeks, deeming the dose-sparing method as safe and effective. While mpox originated in West,...

Read More


More Articles

WHO reports increasing rates of HIV drug resistance to dolutegravir

by Veronica Salib

Earlier this week, the World Health Organization (WHO) issued a news release stating that there are increased trends in human immunodeficiency virus (HIV) drug resistance to dolutegravir. Despite this...

Semaglutide Minimizes MASLD Severity in Patients with HIV

by Veronica Salib

On Tuesday, March 5, 2024, the NIH issued a release linking semaglutide use with a decreased severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in HIV-positive patients,...

Almost Half of Infants in the US Have Received the RSV Vaccine

by Veronica Salib

Last week, the CDC updated data on respiratory syncytial virus (RSV) vaccine uptake in the United States, revealing that almost half of infants in the US have been vaccinated. Additional data provided...

NY Charges Midwife $300K for Falsifying Vaccine Records

by Veronica Salib

Last week, the New York State Department of Health published a press release informing the public about charges against a Nassau County midwife who falsified vaccination records. "Misrepresenting or...

NIH-Developed Antibodies Neutralize HIV in Animal Studies

by Veronica Salib

On January 17, 2024, the National Institutes of Health (NIH) issued a media advisory announcing the results of a proof-of-concept identifying three antibodies that protect against various human...

WHO Urged Actions to Stop Antimicrobial Resistance

by Veronica Salib

The World Health Organization (WHO) recognizes World Antimicrobial Resistance Week from November 18, 2023, to November 24, 2023. Throughout this week, the organization highlights data on antimicrobial...

What to Know About the 2023 Eyedrop Recalls, Understanding the Risks

by Veronica Salib

On February 2, 2023, the first of three eyedrops in the United States were recalled voluntarily after multiple reports of illness associated with the drops were reported to the CDC. Since then, two additional eye drops in the US...

Researchers Reveal Positive Data on New Antibiotic for Super Gonorrhea

by Veronica Salib

On November 1, 2023, the Global Antibiotic Research and Development Partners (GARDP) and Innoviva Specialty Therapeutics, a subset of Innoviva Inc, issued a co-authored press release announcing that a...

Pfizer, BioNTech Reveals Data on Combined COVID and Flu Vaccine

by Veronica Salib

Pfizer and its partner, BioNTech, announced positive clinical trial data for an mRNA-based combined vaccine for influenza and COVID-19. The announcement highlights data from a phase 1/2 clinical study...

CDC Urges Rationing of New Antibody Shot for Infant RSV Protection

by Alivia Kaylor

In response to the overwhelming demand for the newly approved antibody shot, Beyfortus, designed to safeguard newborns from respiratory syncytial virus (RSV), the Centers for Disease Control and...

HHS and Pfizer Reach Paxlovid Agreement to Improve Access

by Veronica Salib

Last week, the United States Department of Health and Human Services (HHS) announced that it had negotiated an agreement with Pfizer Inc. to bolster access to Paxlovid as it enters the commercial...

Antifungal Therapeutic Drug Monitoring Are Rates Lower Than Use Rates

by Veronica Salib

According to the results of an article published in Open Forum Infectious Diseases, infectious disease specialists are not monitoring antifungal prescriptions at the same rates they are prescribing...

FDA Updates Infant Formula Compliance Program

by Veronica Salib

To minimize the risk of contaminated infant formula, the United States Food and Drug Administration (FDA) updated its infant formula compliance program, announcing the changes on October 6, 2023. Last...

10 Things to Know About the Updated 2023 COVID-19 Vaccines

by Alivia Kaylor

With the onset of the fall season, many Americans are grappling with numerous questions about COVID-19 booster shots, the flu vaccine, and respiratory syncytial virus (RSV) protection. This year's vaccine rollout has encountered...

CDC Recommends Doxycycline PEP to Prevent STIs

by Veronica Salib

Earlier this week, the Centers for Disease Control and Prevention (CDC) published a draft guidance for the use of doxycycline, a common antibiotic, as a post-exposure prophylaxis (PEP) treatment to...

Only 46% of US Adults Are Planning to Get the COVID-19 Vaccine Booster

by Veronica Salib

On September 27, 2023, KFF released the results of a survey that assessed how many people plan on getting the newest mRNA COVID-19 vaccine booster. The study's results revealed that only 46% of...

HIV Vaccine Clinical Trials Begin in the US and South Africa

by Veronica Salib

Yesterday, the National Institute of Allergy and Infectious Disease (NIAID), a subset of the National Institutes of Health (NIH), revealed that phase 1 vaccine trials for human immunodeficiency virus...

CDC Updates Recommendations for Pneumococcal Vaccine for Adults

by Veronica Salib

In a Morbidity and Mortality Weekly Report (MMWR) from the United States Centers for Disease Control and Prevention (CDC), public health experts updated pneumococcal vaccination recommendations for...

CDC Follows Listeria Outbreak After Ice Cream Recall

by Veronica Salib

On August 22, 2023, the Centers for Disease Control and Prevention published additional information on a Listeria outbreak linked to a recent food recall. Earlier that month, the United States Food and...

Recent Articles